United States Radiopharmaceutical Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Radiopharmaceutical Markets, Executive Summary Introduction to the U.S. Radiopharmaceuticals MarketIntroduction to the U.S. Radiopharmaceuticals MarketSummary of Major FindingsMarket Growth - Opportunities and Total ForecastCompetitive AnalysisConclusionUnited States Radiopharmaceutical Markets, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsGlossary of TermsUnited States Radiopharmaceutical Markets, Industry ChallengesIdentification of Challenges Facing the U.S. Radiopharmaceutical IndustryIdentification of Challenges Facing the U.S. Radiopharmaceutical IndustryThe Need for Additional Isotope Production in the United States Is Reaching Critical LevelsCompetition from Other Imaging Modalities May Slow Research and Development in the Nuclear Cardiology Radiopharmaceutical IndustryRegulatory Issues on Nuclear Waste Disposal Must Be Addressed for the Future Success of Radioisotope ProductionNuclear Medicine Needs to Integrate with Other Medical Specialties to Increase Demand for Nuclear Medicine Procedures.Small Size of the Therapeutics Market Amplifies Risks Associated with InnovationsHigh R&D Costs Required to Compete Is Forcing Alliances and Driving Out Smaller CompetitorsLikely Fewer Number of Nuclear Physicians May Hurt the Industry in the Near FutureNuclear Physicians Need to Be More Active in the Political Process to Advance the Production and Proliferation of Medical IsotopesTendency to Focus on the Immediate Costs of Nuclear Procedures Discourages Its UseProduction of Isotopes Provides a Unique Challenge to the Private SectorMarket Engineering Measurement Analysis of the Total Radiopharmaceuticals IndustryIntroductionIntroductionMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket AgeRevenuesBase Year Market Growth RateForecast Period Market Growth RateInstalled BaseCompetitorsMarket ConcentrationMarket ShareMarket Engineering Research for the U.S. Diagnostic Radiopharmaceuticals Market 1996-2006Total Market Segment AnalysisMarket OverviewChapter Presentation and LayoutMarket DefinitionOverview of RadiopharmaceuticalsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1996-2006)Competitive StructureEncroachment of Echo and MRI onto Nuclear Cardiology: An End-User PerspectiveMarket Engineering Research for the U.S. Therapeutic Radiopharmaceuticals and Brachytherapy Seeds Market 1996-2006Total Market Segment AnalysisMarket OverviewMarket DefinitionChapter Layout and PresentationMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1996-2006)Competitive StructureUnited States Radiopharmaceutical Markets, Market Engineering StrategyMarket Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsMarketing DepartmentBusiness DevelopmentMarket Engineering Awards for the Radiopharmaceuticals MarketFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Entrepreneurial Company Award Category: Growth Strategy Marketing Engineering Award Category: Market Engineering Leadership




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.